Last Price
3.39
Today's Change
-9.80 (74.29%)
Day's Change
3.00 - 3.49
Trading Volume
21,153,155
Market Cap
156 Million
Shares Outstanding
46 Million
Avg Volume
313,195
Avg Price (50 Days)
14.93
Avg Price (200 Days)
17.76
PE Ratio
-0.19
EPS
-17.59
Earnings Announcement
21-Mar-2025
Previous Close
13.19
Open
3.10
Day's Range
3.0 - 3.49
Year Range
3.0 - 33.92
Trading Volume
21,153,155
1 Day Change
-74.30%
5 Day Change
-75.51%
1 Month Change
-75.36%
3 Month Change
-83.98%
6 Month Change
-79.94%
Ytd Change
-77.48%
1 Year Change
-85.20%
3 Year Change
-76.67%
5 Year Change
-76.67%
10 Year Change
-76.67%
Max Change
-76.67%
No result.
Sector: Healthcare - Healthcare
Industry: Biotechnology
Description:
CARGO Therapeutics, Inc., a clinical-stage biotechnology company, develops chimeric antigen receptor (CAR) T-cell therapies for cancer patients. The company's lead program is CRG-022, an autologous CD22 CAR T-cell product candidate designed to address resistance mechanisms by targeting CD22, an alternate tumor antigen that is expressed in B-cell malignancies. It also develops CRG-023, a tri-specific CAR T product candidate that targets tumor cells with three B-cell antigen targets. The company was formerly known as Syncopation Life Sciences, Inc. and changed its name to CARGO Therapeutics, Inc. in September 2022. CARGO Therapeutics, Inc. was incorporated in 2019 and is headquartered in San Mateo, California.